ProPhase Labs, Inc. (PRPH)

NASDAQ: PRPH · Real-Time Price · USD
0.3580
+0.0008 (0.22%)
At close: Jun 6, 2025, 4:00 PM
0.3459
-0.0121 (-3.38%)
After-hours: Jun 6, 2025, 7:57 PM EDT
0.22%
Market Cap 14.87M
Revenue (ttm) 5.85M
Net Income (ttm) -43.13M
Shares Out 41.54M
EPS (ttm) -1.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 410,825
Open 0.3600
Previous Close 0.3572
Day's Range 0.3500 - 0.3798
52-Week Range 0.2179 - 4.9400
Beta -0.42
Analysts n/a
Price Target n/a
Earnings Date May 20, 2025

About PRPH

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, inc... [Read more]

Sector Healthcare
IPO Date Jan 16, 1997
Employees 96
Stock Exchange NASDAQ
Ticker Symbol PRPH
Full Company Profile

Financial Performance

In 2024, ProPhase Labs's revenue was $6.77 million, a decrease of -80.65% compared to the previous year's $34.98 million. Losses were -$53.36 million, 218.0% more than in 2023.

Financial Statements

News

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the...

2 days ago - GlobeNewsWire

ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Conference Call May 20, 2025 10:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications Ted...

18 days ago - Seeking Alpha

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025

Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has be...

19 days ago - GlobeNewsWire

ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025

GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, announced today th...

26 days ago - GlobeNewsWire

ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Conference Call March 31, 2025 11:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications T...

2 months ago - Seeking Alpha

ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024

Company to Accelerate BE-Smart Commercialization as a Cash-Pay Diagnostic Significantly reduces overhead, improves margins heading into Q2 2025 Company to hold a conference call Monday, March 31, 2025...

2 months ago - GlobeNewsWire

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced...

2 months ago - GlobeNewsWire

ProPhase Labs to Present at the Investor Summit Virtual on March 11

GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announce...

3 months ago - GlobeNewsWire

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

New York, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase La...

3 months ago - GlobeNewsWire

ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs

Company Announces Ongoing Strategic Cost Cutting to Focus Resources on new DTC Marketing Initiatives to Drive Growth and Profitability Dispels rumors of an Investment Bank initiating a Capital Raise G...

3 months ago - GlobeNewsWire

ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables

Company Actively Pursuing Strategic Alternatives Including the Potential Sale of Nebula Genomics and DNA Complete to Unlock Immediate Cash GARDEN CITY, NY, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ProPhase L...

3 months ago - GlobeNewsWire

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

GARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announced...

3 months ago - GlobeNewsWire

ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Results Conference Call November 13, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Execu...

7 months ago - Seeking Alpha

ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024

GARDEN CITY, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that t...

7 months ago - GlobeNewsWire

ProPhase Labs Announces Pricing of Public Offering of Common Stock

GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the pr...

7 months ago - GlobeNewsWire

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025

8 months ago - GlobeNewsWire

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announced that ...

10 months ago - GlobeNewsWire

ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2024 Earnings Conference Call August 14, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Execut...

10 months ago - Seeking Alpha

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

GARDEN CITY, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting second quarter 2024 financial results on a virtual conference call ho...

10 months ago - GlobeNewsWire

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Crea...

11 months ago - GlobeNewsWire

ProPhase Labs: Hidden Gem With An AI Kicker

ProPhase Labs is a diversified biotech company with profitable existing product lines and plans for expansion. The company's subsidiary, Nebula Genomics, offers whole genome sequencing and plans to le...

1 year ago - Seeking Alpha

ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Conference Call May 9, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive ...

1 year ago - Seeking Alpha

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and...

1 year ago - GlobeNewsWire

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap...

1 year ago - GlobeNewsWire

ProPhase Labs Unveils Project ZenQ-AI

Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development.

1 year ago - GlobeNewsWire